FIELD: medicine.
SUBSTANCE: invention can be used to predict chronic fetal hypoxia (CFH) in women pregnant using IVF. For this purpose, before the IVF procedure, the content of thyroid-stimulating hormone is determined in venous blood and with a value of more than 1.92 mIU/l, CFH development is predicted.
EFFECT: method allows to increase the accuracy and specificity of chronic fetal hypoxia prediction in women pregnant through in vitro fertilisation method, with simplicity of execution to allocate risk groups in terms of chronic fetal hypoxia development for timely preventive measures.
1 tbl, 4 ex
Authors
Dates
2017-12-19—Published
2016-06-24—Filed